Neogenomics (NEO) Deferred Taxes (2022 - 2026)

Neogenomics has reported Deferred Taxes for 5 years, with the latest figure at $769000.0 in Q1 2026.

• For the quarter ending Q1 2026, Deferred Taxes rose 42.14% year-over-year to $769000.0; the trailing twelve-month figure through Mar 2026 stood at $3.6 million (up 27.38% YoY), and the FY2025 full-year result was $3.4 million, up 9.41% from the prior year.
• Deferred Taxes for Q1 2026 stood at $769000.0, down from $2.7 million in the prior quarter.
• The five-year high for Deferred Taxes was $5.7 million in Q2 2022, with the low at -$869000.0 in Q3 2025.
• Historically, Deferred Taxes has averaged $2.0 million across 5 years, with a median of $1.8 million in 2023.
• The largest YoY upside for Deferred Taxes was 109.05% in 2025 against a maximum downside of 456.15% in 2025.
• Neogenomics' Deferred Taxes stood at $3.3 million in 2022, then tumbled by 45.34% to $1.8 million in 2023, then retreated by 14.18% to $1.6 million in 2024, then soared by 73.14% to $2.7 million in 2025, then plunged by 71.46% to $769000.0 in 2026.
• The last three Deferred Taxes figures came in at $769000.0 (Q1 2026), $2.7 million (Q4 2025), and -$869000.0 (Q3 2025), per Business Quant data.